| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453480 | Leukemia Research | 2016 | 6 Pages |
Abstract
More efforts are needed to provide more systematic information about AML risk to patients wishing to know it. More research is needed to study if increasing awareness can lead to more active engagement of MDS patients in their care and can increase the rate of clinical trial participation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Youssoufa M. Ousseine, Phyllis N. Butow, Claire Julian-Reynier, Rebecca Dring, Patrick Festy, Pierre Fenaux, Norbert Vey, Julien Mancini,